Executive Summary
On January 6, 2026, a surge of 170 8-K filings revealed widespread corporate activity dominated by executive transitions (Item 5.02 across ~40 filings), material definitive agreements/financings (Item 1.01/2.03 in ~30), and Reg FD disclosures (Item 7.01 frequently), with neutral sentiment overall but pockets of high-risk restructurings including delistings. Within the S&P 500 Financials stream (banks, insurers, asset managers), activity was subdued and routine—featuring officer changes at firms like Fidelity D&D Bancorp, AIG, and Reg FD/shareholder votes at majors like BAC, CMA, FITB, HBAN—implying sector stability amid broader market churn. Cumulative implications: minimal systemic stress for Financials but elevated uncertainty from undisclosed details signals potential volatility; portfolio managers should prioritize governance monitoring over panic.
Tracking the trend? Catch up on the prior S&P 500 Financials Sector SEC Filings digest from January 04, 2026.
Investment Signals(4)
- ▲
Multiple material agreements and financings (e.g., BayFirst Financial, TPG Inc., Comerica) suggest consolidation/strategic growth in banks/asset managers [BULLISH] - Financials subset
- ▲
Routine Reg FD disclosures and shareholder votes at BAC, FITB, HBAN indicate transparency and governance health [BULLISH] - S&P 500 banks
- ▲
Pervasive unregistered equity sales (Item 3.02, e.g., TPG, Jackson Financial) across filings flag dilution risks [BEARISH] - Financials and broader
- ▲
Delistings (e.g., Mersana, Immunic) though non-Financials, correlate with restructuring wave potentially spilling into sector M&A [BEARISH] - Cross-sector
Risk Flags(3)
- ▼
Executive churn (Item 5.02 in dozens, including Financials like AIG, Fidelity D&D Bancorp) signals potential leadership instability and governance risks at portfolio level
- ▼
Undisclosed financial obligations/equity issuances (Item 2.03/3.02 frequent) heighten dilution and leverage concerns, especially in banks/insurers amid rising rates
- ▼
Delistings and control changes (e.g., Mersana, Compass Diversified) highlight liquidity/systemic listing risks, warranting Financials exposure review
Opportunities(3)
- ◆
M&A/financing wave (Item 1.01/2.01, e.g., Investar Holding acquisition completion) offers alpha in consolidating Financials subsector like regional banks
- ◆
Reg FD updates from BAC, FITB signal operational clarity for long positions in stable S&P 500 banks amid neutral sentiment
- ◆
Officer appointments in asset managers/insurers (e.g., TPG) could catalyze strategic pivots if positive succession
Sector Themes(3)
- Governance flux◆
Heavy Item 5.02 activity in Financials (AIG, regional banks) mirrors broader turnover, potentially presaging strategic resets or performance issues
- Financing/debt activity◆
Item 1.01/2.03 clusters indicate capital raising amid tight liquidity, bullish for growth-oriented Financials but risky for leveraged players
- Disclosure transparency◆
Frequent Item 7.01/5.07 in S&P 500 banks (BAC, CMA) underscores compliance focus, differentiating stable majors from volatile small-caps
Watch List(4)
- 👁
Bank of America (BAC), Comerica (CMA), Fifth Third (FITB), Huntington (HBAN) - Shareholder votes/Reg FD for guidance catalysts
- 👁
AIG, Jackson Financial (JXN), TPG Inc. - Officer changes and equity sales for leadership/ dilution impacts
- 👁
Regional banks (Fidelity D&D, Axos, BayFirst, Investar) - Material agreements for M&A consolidation plays
- 👁
Delisting precursors (Mersana, Immunic) - Broader restructuring contagion to Financials via sector correlations
Filing Analyses(170)
06-01-2026
Mersana Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001125), disclosing termination of a material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departure/election of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and change in fiscal year (Item 5.03), and financial statements/exhibits (Item 9.01). The filing signals a major corporate restructuring event, likely a merger or acquisition resulting in change of control and delisting, with no specific parties, valuation, or consideration disclosed. All numerical values, deal terms, and strategic details are NOT_DISCLOSED.
06-01-2026
Marblegate Capital Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003211, Size: 7 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling a potentially significant agreement and financial obligation.
06-01-2026
UMH Properties, Inc. filed a general filing (8-K) on January 6, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or quantitative data are specified in the provided information. All specific impacts and numbers are NOT_DISCLOSED.
06-01-2026
Geron Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003388), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's terms, parties, value, or strategic context are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Jackson Financial Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000968, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction values, share counts, financial metrics, or other numerical details disclosed in the provided information. All quantitative data such as dollar values or percentages is NOT_DISCLOSED.
06-01-2026
Calumet, Inc. (/DE) filed Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003207, Size: 206 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, percentages, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Athena Technology Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001373), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on merger/acquisition structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing summary. Sector not specified; all deal-related information is NOT_DISCLOSED.
06-01-2026
Steel Dynamics Inc filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000833, Size: 253 KB) under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). This is a general filing from the US SEC with no sector specified. No specific details on the Regulation FD disclosure content or exhibits are provided in the filing summary.
06-01-2026
Twenty One Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001442, Size: 196 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the summary.
06-01-2026
IGC Pharma, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001185185-26-000032, size: 305 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No details on the agreement, transaction value, or other specifics provided.
06-01-2026
AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000461, Size: 586 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or counterparties disclosed in the provided information. Core event involves a material agreement creating financial obligations and equity sales.
06-01-2026
News Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001564708-26-000003, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the financial statements and exhibits are provided in the filing summary. Sector is not specified.
06-01-2026
Alussa Energy Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001319, Size: 265 KB) under Items 8.01 Other Events and 9.01 Financial Statements and Exhibits, announcing a Merger/Acquisition event. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
American Drive Acquisition Co filed an 8-K on 2026-01-06 (AccNo: 0001104659-26-000809, Size: 420 KB) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Kyndryl Holdings, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001104659-26-001053, Size: 185 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, reason for change, or any numerical data are provided in the available information. Sector is not specified.
06-01-2026
TPG Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003402, Size: 7 MB), reporting Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Core event involves unregistered equity sales and Regulation FD disclosure.
06-01-2026
Compass Diversified Holdings filed a Form 8-K on January 6, 2026 (AccNo: 0001345126-26-000005, Size: 238 KB), reporting a delisting-related event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) and Item 9.01 (Financial Statements and Exhibits). No specific details on the delisting reasons, transaction values, financial impacts, or other quantitative metrics are disclosed. Sector is not specified.
06-01-2026
Fidelity D & D Bancorp Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000408, Size: 178 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 06, 2026. No specific details on officer name, position, appointment/resignation, reason, or quantitative data provided.
06-01-2026
Alkermes plc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003453), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with a file size of 204 KB; sector not specified. No core event details, transaction values, financial metrics, or named entities beyond the filer are explicitly stated.
06-01-2026
SmartKem, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-001067; File Size: 191 KB. No details on the specific event, transaction, or financial impacts are disclosed.
06-01-2026
Abpro Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001570, Size: 274 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Genprex, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001437749-26-000437, Size: 173 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, or exhibits content are provided in the filing summary. Sector not specified.
06-01-2026
FRACTYL HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003452, Size: 632 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, board impacts, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. All leadership, governance, succession, and market impact details are NOT_DISCLOSED.
06-01-2026
Trinity Industries Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000099780-26-000006, Size: 702 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
06-01-2026
Apogee Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001063, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other content are disclosed in the provided filing summary.
06-01-2026
Sunrun Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003449, Size: 1 MB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Item 9.01 includes Financial Statements and Exhibits. No transaction details, dollar values, or other quantitative data are provided in the filing summary.
06-01-2026
D-Wave Quantum Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001907982-26-000005, Size: 158 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for Regulation FD updates, with no core event, transaction details, or financial metrics specified. Sector not specified.
06-01-2026
McGraw Hill, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003463, Size: 420 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Sunoco LP filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003460, Size: 166 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, transaction, financials, or exhibits are provided in the filing summary. Sector not specified.
06-01-2026
ALUMIS INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001073, Size: 14 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
06-01-2026
AngioDynamics Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000341), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific quantitative data, transaction details, or financial metrics are mentioned in the provided filing information.
06-01-2026
Aclaris Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001076, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
KALA BIO, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001829126-26-000055), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Sector is not specified.
06-01-2026
Six Flags Entertainment Corporation filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003472, Size: 268 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.
06-01-2026
Realty Income Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001089, Size: 369 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Energy Vault Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001828536-26-000003, Size: 265 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.
06-01-2026
Transcode Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001097, Size: 210 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure under Regulation FD, with no core event, transaction details, financial metrics, or named entities beyond the filer specified in the filing metadata. Sector is not specified.
06-01-2026
REPLIGEN CORP filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-003467), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, appointment/resignation status, or any quantitative data provided in the filing summary. Sector not specified.
06-01-2026
Milestone Pharmaceuticals Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001099, Size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial data, transaction values, and strategic impacts are NOT_DISCLOSED.
06-01-2026
Edible Garden AG Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001477932-26-000041, size: 187 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard financial results disclosure.
06-01-2026
Archrock, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001091, Size: 267 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content or exhibits are provided. Sector is not specified.
06-01-2026
Compass Digital Acquisition Corp. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000508, Size: 25 MB), disclosing a Merger/Acquisition event under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.
06-01-2026
Mineralys Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001933414-26-000002, Size: 173 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific event details, transaction values, or financial metrics disclosed in the summary. Sector is not specified.
06-01-2026
HALLADOR ENERGY CO filed a Form 8-K on 2026-01-06 (AccNo: 0001104659-26-001098, Size: 191 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Event classified as Officer Change; sector not specified.
06-01-2026
Denali Therapeutics Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001714899-26-000004, Size: 242 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector not specified.
06-01-2026
XBP Global Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001093, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
06-01-2026
Installed Building Products, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000785, Size: 249 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction values, financial impacts, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item filing involving Regulation FD compliance and attached exhibits.
06-01-2026
Dare Bioscience, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000513, Size: 10 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary. Sector not specified.
06-01-2026
Compass Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000083, Size: 232 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific revenue, earnings, transaction values, or other quantitative metrics mentioned. Sector is not specified.
06-01-2026
Digi Power X Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001580, Size: 234 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of material non-public information and attachment of related exhibits. No specific details on the content of the disclosure, exhibits, transaction values, financial metrics, or other quantitative data are provided in the filing summary.
06-01-2026
Calumet, Inc. (/DE) filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003479, Size: 189 KB), disclosing under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.
06-01-2026
NORTECH SYSTEMS INC filed a Form 8-K on 2026-01-06 (AccNo: 0001493152-26-000512, Size: 362 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Earth Science Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000511, size 242 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided. Sector is not specified.
06-01-2026
Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001527541-26-000004, Size: 205 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Cyclerion Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003509, Size: 8 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with sector not specified. No quantitative data, transaction details, or other specifics disclosed in the provided information.
06-01-2026
Silexion Therapeutics Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001178913-26-000067, Size: 283 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD.
06-01-2026
MOBIX LABS, INC filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000515, Size: 329 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
06-01-2026
Ainos, Inc. filed a Form 8-K on January 06, 2026, under Item 8.01 Other Events. Accession number: 0001493152-26-000517; file size: 244 KB. No details on the specific event, transaction, financials, or other quantitative data are provided.
06-01-2026
Galecto, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003490, Size: 485 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer position, name, appointment/resignation status, reasons, or quantitative data such as share counts or transaction values are provided. Sector is not specified.
06-01-2026
Aspire Biopharma Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000518, Size: 447 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on the agreement, transaction value, share count, or parties provided in the summary. All financial metrics, dollar values, and quantitative impacts are NOT_DISCLOSED.
06-01-2026
Atossa Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003506, Size: 209 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with limited information available.
06-01-2026
eHealth, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001333493-26-000003), reporting multiple events including entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed. Core events suggest significant corporate restructuring, but all key metrics are NOT_DISCLOSED.
06-01-2026
SS Innovations International, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001594, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary.
06-01-2026
ESS Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001819438-26-000003, Size: 239 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.
06-01-2026
STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003534, Size: 151 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
LifeMD, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000525, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, or other numerical data disclosed in the provided information. Sector is not specified.
06-01-2026
Lantronix Inc. filed an 8-K on January 6, 2026 (AccNo: 0001683168-26-000113, Size: 204 KB) disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. Specific details including key position affected, appointment/resignation status, reasons, names, or quantitative data are NOT_DISCLOSED.
06-01-2026
Ford Motor Co filed an 8-K on January 6, 2026 (AccNo: 0000037996-26-000002, size 1 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided summary. Sector not specified.
06-01-2026
Ocean Power Technologies, Inc. filed a Form 8-K on January 6, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits). The filing has Accession Number 0001493152-26-000524 and a size of 269 KB. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided information.
06-01-2026
MOTORCAR PARTS OF AMERICA INC filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000345, Size: 165 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions, individuals, reasons, or compensation are provided.
06-01-2026
Day One Biopharmaceuticals, Inc. announced via 8-K filing on January 06, 2026 (AccNo: 0001104659-26-001127, Size: 8 MB), entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No details on parties involved, deal structure, valuation, consideration, or strategic rationale are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
QHSLab, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000527, Size: 262 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the content of the Regulation FD disclosure or attached exhibits are provided. Sector is not specified.
06-01-2026
Lottery.com Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000531, Size: 265 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), person involved, appointment/resignation status, reasons, or timing are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Harvard Apparatus Regenerative Technology, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000452, Size: 341 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing from the US SEC source. No specific transaction details, amounts, or financial metrics are disclosed in the provided summary.
06-01-2026
NLIGHT, INC. filed a Form 8-K on 2026-01-06 (AccNo: 0001124796-26-000003, Size: 158 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative impacts are provided.
06-01-2026
Choice Hotels International Inc./DE filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000795, Size: 151 KB) disclosing an officer change under Item 5.02. The item covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions, reasons, or financial details are provided in the summary.
06-01-2026
Belden Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000913142-26-000003, Size: 146 KB) disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected officers, positions, reasons, or compensatory arrangements are provided. Sector not specified.
06-01-2026
Table Trac Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001437749-26-000465, size 152 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment or resignation, reasons, or compensatory arrangements are provided in the summary. Sector is not specified.
06-01-2026
ScanTech AI Systems Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001227, Size: 240 KB), reporting Items 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, or financial impacts provided. Sector not specified.
06-01-2026
SELECTIS HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000558, Size: 199 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any compensatory arrangements are provided. Sector is not specified, and no quantitative financial data such as transaction values, share counts, or percentages is mentioned.
06-01-2026
AIxCrypto Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000561, Size: 243 KB), reporting Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no further details provided on vote outcomes, disclosure content, or exhibits. Sector not specified.
06-01-2026
Profound Medical Corp. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000096, Size: 228 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with sector not specified. No details on the core event, transaction values, financial impacts, or other specifics are disclosed in the provided information.
06-01-2026
HOME BANCORP, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000838, Size: 195 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transactions, financial metrics, or entities are explicitly stated in the provided filing summary.
06-01-2026
Axos Financial, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001299709-26-000003, file size: 217 KB. No details on the specific event, transaction, or financial impacts are disclosed.
06-01-2026
SolarMax Technology, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001640334-26-000032, Size: 1 MB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event, but specific details on the agreement, transaction terms, or disclosures are NOT_DISCLOSED. No quantitative financial data or named entities beyond the filer are provided.
06-01-2026
Immunic, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193805-26-000011, Size: 188 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This discloses a delisting event from the US market. No additional details on reasons, financial impacts, or transaction values are provided.
06-01-2026
Air Lease Corp filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004412, Size: 219 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided.
06-01-2026
CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001785, Size: 200 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item, mandatory disclosure under SEC rules for shareholder meeting results. No specific vote details, proposals, outcomes, or quantitative data are disclosed.
06-01-2026
Newton Golf Company, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000591, Size: 234 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Arrowhead Pharmaceuticals, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0000879407-26-000004, Size: 8 MB) reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financials, or exhibits are disclosed in the provided filing summary. Sector not specified.
06-01-2026
INVO Fertility, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000592, Size: 394 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including key position affected, appointment or resignation, reasons, compensation, or any quantitative financial metrics are NOT_DISCLOSED. Event type is Officer Change; sector not specified.
06-01-2026
Aimei Health Technology Co., Ltd. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000589, Size: 322 KB), reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No transaction details, dollar values, or other quantitative data are specified.
06-01-2026
OCTAVE SPECIALTY GROUP INC filed a Form 8-K on January 06, 2026 (AccNo: 0001628280-26-000870, Size: 1 MB), reporting under Item 9.01 Financial Statements and Exhibits. No details on the specific financial statements, exhibits, or associated events/transactions are disclosed. Sector not specified.
06-01-2026
PennantPark Floating Rate Capital Ltd. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000103, Size: 225 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a general filing from the US SEC with no further details on the disclosure content provided. Sector not specified.
06-01-2026
PENNANTPARK INVESTMENT CORP filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000104, Size: 226 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosures, core events, transactions, financial metrics, or named entities are explicitly stated in the filing summary. All quantitative data and specific impacts are NOT_DISCLOSED.
06-01-2026
Dror Ortho-Design, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001784, size 778 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed in the provided information. Sector is not specified.
06-01-2026
Electronic Arts Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000712515-26-000002, Size: 145 KB), reporting under Item 1.02 the termination of a material definitive agreement, under Item 2.04 triggering events that accelerate or increase a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events. No specific details on the core event, transaction value, parties involved, financial impacts, or timelines are disclosed in the provided filing summary. This is a multi-item filing likely mandatory given the material nature.
06-01-2026
CSG Systems International Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004380, size: 150 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are provided in the filing summary. Sector not specified.
06-01-2026
Comerica Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004372, size 278 KB), disclosing Items 5.07 (Submission of Matters to a Vote of Security Holders), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on vote results, disclosures, or exhibits. Sector not specified.
06-01-2026
Spectral AI, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001781, Size: 240 KB), disclosing an event under Item 5.02 related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the available filing summary. Sector is not specified.
06-01-2026
Pixelworks, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001040161-26-000002, Size: 173 KB) announcing under Item 2.01 the completion of an acquisition or disposition of assets. The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial impacts are disclosed in the provided summary.
06-01-2026
CHS INC filed a Form 8-K on January 6, 2026 (AccNo: 0000823277-26-000003, Size: 208 KB) reporting under Item 8.01 Other Events. No specific details of the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
PMGC Holdings Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001782, Size: 3 MB) as a multi-item disclosure covering Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, named entities beyond the filer, or quantitative impacts are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Fifth Third Bancorp filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004377, Size: 278 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing covering shareholder vote results and voluntary Regulation FD disclosure. No financial metrics, transaction details, or quantitative impacts are disclosed.
06-01-2026
Flora Growth Corp. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001062993-26-000078, Size: 227 KB), under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors/officers, and compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or terms are provided. Sector is not specified.
06-01-2026
Direct Digital Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001880613-26-000003), reporting an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), submission of matters to a vote of security holders under Item 5.07, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Estrella Immunopharma, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001777, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction terms, parties, values, or financial impacts provided in the summary. Sector is not specified.
06-01-2026
HA Sustainable Infrastructure Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004493, Size: 144 KB) reporting under Item 9.01 Financial Statements and Exhibits. No specific financial statements, exhibits, transaction details, or numerical values are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Blend Labs, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001855747-26-000003, Size: 156 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure compliant with Regulation FD requirements.
06-01-2026
MidWestOne Financial Group, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001412665-26-000003, size 145 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific event, transaction, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item filing with limited transparency on content.
06-01-2026
BayFirst Financial Corp. filed an 8-K on 2026-01-06 (AccNo: 0001649739-26-000003, Size: 183 KB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, parties, or exhibits provided in the available summary. Sector not specified.
06-01-2026
Trailblazer Merger Corp I filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001799, Size: 256 KB) under Item 8.01 Other Events announcing a Merger/Acquisition event. No details on deal structure, parties involved, valuation, consideration, synergies, regulatory pathway, shareholder impact, or market implications are disclosed in the provided filing information. Sector is not specified.
06-01-2026
Tradeweb Markets Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001758730-26-000008, Size: 165 KB), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, transaction value, or financial terms are disclosed in the provided filing summary. All specific quantitative data and named entities beyond the filer are NOT_DISCLOSED.
06-01-2026
NUSATRIP Inc filed an 8-K on January 06, 2026 (AccNo: 0001493152-26-000607, Size: 253 KB), reporting a change in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the reasons for the accountant change, financial impacts, or transaction values are disclosed. Sector not specified.
06-01-2026
Adial Pharmaceuticals, Inc. disclosed an officer change via SEC Form 8-K filed on January 6, 2026 (AccNo: 0001213900-26-001790, Size: 187 KB). The filing pertains to Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on individuals, positions, reasons, or compensation are provided in the available information.
06-01-2026
Samsara Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000886, Size: 139 KB), reporting under Item 8.01 Other Events. No specific details on the core event, transaction, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
MV Oil Trust filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001311, Size: 35 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, revenue, earnings, or other quantitative data are disclosed in the provided filing summary. This is a financial results disclosure for the US market, sector not specified.
06-01-2026
Society Pass Incorporated filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000606), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. No details on the accountants involved, reasons for change, or any quantitative financial impacts are disclosed in the provided filing summary. All specific transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
06-01-2026
Penguin Solutions, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001616533-26-000008, size 839 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector not specified.
06-01-2026
CEA Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000598, size 258 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Tredegar Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004456, Size: 145 KB), disclosing an Item 5.02 event involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Regional Health Properties, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004436), reporting under Item 5.07 the submission of matters to a vote of security holders. This is a single-item filing with no additional details on voting matters, outcomes, or numerical data provided in the summary. Item 5.07 disclosures are mandatory for shareholder vote results.
06-01-2026
NATIONAL PRESTO INDUSTRIES INC filed a Form 8-K on January 06, 2026 (AccNo: 0001437749-26-000614, Size: 165 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Leonardo DRS, Inc. disclosed an officer change via Form 8-K filed on January 06, 2026 (AccNo: 0001833756-26-000002, Size: 163 KB), under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or any quantitative data are provided in the filing summary. Sector not specified.
06-01-2026
MATRIX SERVICE CO filed a Form 8-K on January 6, 2026 (AccNo: 0000866273-26-000006, Size: 142 KB), disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals, reasons for change, or quantitative data are provided. Sector is not specified.
06-01-2026
Barinthus Biotherapeutics plc. filed a Form 8-K on January 6, 2026 (AccNo: 0001828185-26-000004, Size: 190 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No details on delisting reasons, transaction values, financial impacts, or related entities are disclosed. Sector is not specified.
06-01-2026
Quipt Home Medical Corp. filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001322, Size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
One Stop Systems, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-004552, Size: 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also includes Regulation FD disclosure (Item 7.01) and financial statements and exhibits (Item 9.01). No specific details on parties, structure, valuation, or financial terms are provided.
06-01-2026
AAR CORP filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001328, size: 4 MB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative details are provided in the filing summary. Sector is not specified.
06-01-2026
Gladstone Land Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004612, Size: 211 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary multi-item disclosure with no quantified impacts mentioned.
06-01-2026
Praxis Precision Medicines, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001689548-26-000002, Size: 149 KB) under Item 2.02 reporting Results of Operations and Financial Condition. No specific financial metrics, transaction details, revenue, earnings, or quantitative data are disclosed in the provided filing information. Sector is not specified.
06-01-2026
Jushi Holdings Inc. disclosed an officer change via Form 8-K filed on January 6, 2026 (AccNo: 0001628280-26-000908, Size: 355 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position, nature of change (appointment/resignation), reasons, or quantitative data are provided.
06-01-2026
T-Mobile US, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004596, Size: 1 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No details on the specific agreement, transaction value, parties involved, or financial terms are disclosed in the provided summary. This is a multi-item mandatory filing likely related to a financing or debt arrangement.
06-01-2026
Tetra Tech Inc filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001352, Size: 222 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Other Events (Item 8.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the officer's name, position, nature of change (appointment or resignation), reasons, or compensation are provided. Sector is not specified.
06-01-2026
Caterpillar Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001346, Size: 637 KB), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are disclosed in the provided filing summary. Sector information is not specified.
06-01-2026
Mobileye Global Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001340), disclosing Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific details on the agreement, securities sale, transaction value, or financial impacts provided in the available information. Sector not specified.
06-01-2026
Oncotelic Therapeutics, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000613, Size: 208 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, or quantitative data disclosed in the provided summary. Sector not specified.
06-01-2026
PLUG POWER INC filed an 8-K on January 6, 2026 (AccNo: 0001104659-26-001336, size 314 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial impacts are disclosed in the provided filing summary. Sector not specified.
06-01-2026
Awaysis Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000614, Size: 193 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters voted upon, results, or outcomes are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
LM Funding America, Inc. filed a Form 8-K on January 6, 2026, reporting under Item 8.01 Other Events. The filing has accession number 0001193125-26-004587 and file size of 162 KB. Sector is not specified, and no details on the event are provided.
06-01-2026
United Parks & Resorts Inc. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0001193125-26-004574, Size: 141 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on the affected position, individual names, appointment/resignation status, reasons, or other quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Becton Dickinson & Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004659), reporting under Item 5.04 a temporary suspension of trading under the registrant's employee benefit plans. No details on duration, reasons, financial impact, or transaction sizes are disclosed. This appears to be a compliance-related disclosure with no quantified elements provided.
06-01-2026
Flowers Foods Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004576, Size: 176 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Event type is Officer Change from US SEC source.
06-01-2026
Bank of America Corp /DE/ filed a General Filing (likely Form 8-K) on January 06, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). Accession Number: 0000070858-26-000011, File Size: 3 MB. No specific event details, financial data, or transaction information disclosed in the provided summary.
06-01-2026
SMITH A O CORP filed a Form 8-K on January 06, 2026 (AccNo: 0000091142-26-000003, size 33 MB), reporting under Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No details on the specific obligation, events, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary. This is a multi-item mandatory filing as per SEC 8-K requirements.
06-01-2026
Powell Industries Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0000080420-26-000009, Size: 141 KB), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
06-01-2026
Rare Element Resources Ltd filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001387, Size: 218 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
06-01-2026
VEEA INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001835, size 254 KB), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on the matters submitted, vote outcomes, or any numerical data are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Cibus, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001628280-26-000957, File Size: 135 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
06-01-2026
Westlake Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001262823-26-000005, Size: 201 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, transactions, or financial data are provided in the filing summary. This appears to be a multi-item filing involving voluntary Regulation FD disclosure with attached exhibits.
06-01-2026
Middleby Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004740, size 160 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, counterparties, transaction value, or financial impacts are disclosed in the provided summary. Sector not specified.
06-01-2026
STAAR Surgical Co filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004699, size 141 KB), disclosing under Item 1.02 the termination of a material definitive agreement and under Item 5.07 the submission of matters to a vote of security holders. No details on the agreement, vote outcomes, dollar values, or financial impacts are provided in the summary. Sector not specified.
06-01-2026
Celanese Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001306830-26-000003, Size: 256 KB), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or certain officers, and compensatory arrangements. Item 9.01 lists financial statements and exhibits. No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary.
06-01-2026
Skyward Specialty Insurance Group, Inc. filed an 8-K on 2026-01-06 (AccNo: 0001519449-26-000002, Size: 3 MB) announcing Item 1.01 Entry into a Material Definitive Agreement, Item 2.01 Completion of Acquisition or Disposition of Assets, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This indicates completion of a merger/acquisition event, but all specific deal structure, parties, valuation, consideration, synergies, regulatory details, and financial impacts are NOT_DISCLOSED.
06-01-2026
GigCapital7 Corp. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-004729, Size: 11 MB), reporting an Other Event under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the event, transaction, or exhibits are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
Neuronetics, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-004728, Size: 133 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the officer's name, position, nature of change (appointment/resignation), reasons, or compensation are NOT_DISCLOSED. Sector is not specified.
06-01-2026
Berkshire Hathaway Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004727, Size: 237 KB), disclosing an Item 5.02 event related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or other quantitative data provided in the filing summary. Sector not specified.
06-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000619, Size: 225 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), along with Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, parties, transaction value, or financial terms are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.
06-01-2026
Instil Bio, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001789769-26-000004, Size: 146 KB) disclosing under Item 1.02 the termination of a material definitive agreement. Sector not specified. No details on the agreement counterparties, value, financial impacts, or strategic rationale provided.
06-01-2026
Laser Photonics Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000629), reporting changes in its certifying accountant under Item 4.01 and financial statements and exhibits under Item 9.01. This is a multi-item mandatory disclosure with no details on the prior/new auditor, reasons for change, or quantitative impacts provided. Core event is the auditor change, a potential governance red flag.
06-01-2026
Murphy Oil Corp filed a Form 8-K on January 6, 2026 (AccNo: 0000950103-26-000187, size 12 MB), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source, but specific details on transactions, financial metrics, dollar values, or impacts are NOT_DISCLOSED. Sector is not specified.
06-01-2026
COMMUNITY FINANCIAL SYSTEM, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001402, size 203 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or individuals are provided. Sector is not specified.
06-01-2026
Investar Holding Corp filed an 8-K on January 06, 2026 (AccNo: 0001437749-26-000650, Size: 183 KB), disclosing completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), departure/election of directors/officers or compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific parties, transaction value, deal structure, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
06-01-2026
INTERGROUP CORP filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000636, Size: 219 KB), disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
06-01-2026
Safe & Green Development Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001868, Size: 483 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 includes Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties, or financial terms are disclosed in the provided information.
06-01-2026
AMERICAN INTERNATIONAL GROUP, INC. disclosed an officer change via Form 8-K filed on 2026-01-06 (AccNo: 0000005272-26-000006, Size: 211 KB). Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 9.01 references Financial Statements and Exhibits; no specific details on positions, reasons, or names provided.
06-01-2026
OneStream, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-004772, Size: 1 MB), reporting multiple items: Item 1.01 (Entry into a Material Definitive Agreement), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details, transaction values, or financial metrics disclosed in the provided information. Sector not specified.
06-01-2026
CareView Communications Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000653, Size: 316 KB) reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No details on transaction parties, value, terms, or financial metrics are disclosed in the provided summary. Sector not specified.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 170 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC